Call for abstracts

Abstract submission has been closed.
Abstract Submission Deadlines:

  Wednesday, 25 November 2009 Nurses Group
  Monday, 14 December 2009 Physicians & Data Management Group

 

All participants are invited to submit abstracts on one of the topics listed below for presentation at the EBMT 2010.

 

The three different abstract submissions, one each for physicians, nurses and the data management group, are listed at the end of this page. Please make sure to select the appropriate link.

 

In order to standardize the abstract layout we ask you to read the preparation guidelines at this link CAREFULLY! Avoid submission within 48 hours of the deadline for best system performance.

 

Late abstracts will not be considered.

 

 

Guideline for submission of abstracts

  1. Abstracts may be submitted only via Internet. Abstracts submitted via fax or e-mail will not be accepted.
  2. All abstracts must be submitted and presented in English.
  3. Abstracts should contain original material neither published nor presented elsewhere prior to 21 March 2010.
  4. With internet submission of an abstract the author(s) transfer(s) all copyright ownership to the European Group for Blood and Marrow Transplantation.
  5. Abstracts should be informative, containing objectives, methods, results and a conclusion. Just the promise of further data and discussion is not acceptable.
  6. The abstract text may not be longer than 2’500 characters, including spaces.
  7. Tables, charts and other graphics are permitted and must be in JPG or GIF format, of high resolution and suitable for reproduction in black & white. A separate upload button is provided (max 2 graphics per abstract). No photos may be submitted.
  8. Avoid complex mathematical formulae, Greek letters and symbols. For the symbols ≤ or ≥, type instead <= or >=. For superscript use caret (^) e.g. 10^6 instead of 106. Instead of ‘IFN-γ’ use for example ‘IFN-g’ or ‘IFN-gamma’, etc.
  9. All abbreviations must be defined the first time they appear in your text (but, do not define in the title). Example: Graft-versus-host disease (GvHD), before being used as an abbreviation only.
  10. Authors are requested to select a topic under which they wish their abstract to be reviewed.
  11. Authors should indicate their preferred method of presentation:
    • Oral Presentation
    • Poster Presentation
    • Oral or Poster Presentation
    The selection committee reserves the right to decide on the final allocation and presentation method.
  12. If an abstract is accepted, the presenting author must register and attend the congress. Acceptance of a paper implies payment of the registration fee by the presenting author.
  13. After having submitted your abstract, you will receive a confirmation by e-mail with the following information (please make sure to state your correct email address):
    • reference number of your abstract (for correspondence and questions that might arise)
    • your personal access codes

 

Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use these access codes.

 

If you do not receive a confirmation by e-mail please contact the Abstract hotline:
+41 61 686 77 22

 

 

 

Corrections to abstracts can only be made up to the deadlines of:

 

Wednesday, 25 November 2009 Nurses Group or
Monday, 14 December 2009 Physicians & Data Management Group
(after these dates no abstracts or changes may be accepted!)

 

If you have difficulties in submitting your abstracts or
if you need any further information, please contact the Abstract hotline

Phone: +41 61 686 77 22
(Monday - Friday during CET business hours).

 

Notification

Abstracts are subject to approval by the scientific committee and to final assignment for inclusion in the programme as an oral or poster presentation.
Authors from the Nurses Group will be notified in mid December 2009.
Authors form the Physicians and Data Management Group will be notified at the end of January 2010. All authors will be contacted by e-mail (therefore it is essential that you indicate your correct e-mail address). Authors will be informed as to whether they are to present their abstract orally or in the form of a poster. Full instructions concerning the preparation and presentation will be included.

 

Publication

All accepted abstracts will be published in a Supplement of the Bone Marrow Transplantation Journal as well as on CD-ROM, available at the congress. Full abstract texts will be viewable on the EBMT 2010 website two weeks prior to the congress.

 

Basic Science Award for Physicians

This award will be presented to the best basic science abstract submitted under any relevant topic. The aim of this award is to increase the level of basic science at the meeting and particularly young investigators are encouraged to submit their work. The prize winning abstract will be selected from the top-scoring abstracts by a Scientific Committee headed by the Chairs of the EBMT Developmental Committee.
Authors submitting a basic science abstract are invited to tick the respective box in the online submission, thus indicating the wish to be considered for the Basic Science Award. The prize-winning abstract will be presented as part of the Presidential Symposium on Monday, 22 March 2010. This year’s prize of € 2’000 is generously supported by Genzyme Europe B.V.

 

 

Main Topics for Abstract Submission

Please carefully select the topic under which you wish to submit your abstract for review. Abstracts not submitted under an appropriate topic may be incorrectly reviewed and rejected.

 

 

Physicians

 

General Topics

  1. Cellular and gene therapies
  2. Cytokines
  3. Stem cell research

 

Transplant-specific topics

  1. Stem cell source
  2. Graft engineering
  3. Stem cell donor
  4. Graft-versus-host disease – preclinical and animal models
  5. Graft versus host disease – clinical
  6. Infectious complications
  7. Early side effects / Late effects & quality of life
  8. Reduced-intensity conditioning
  9. Minimal residual disease
  10. Paediatric issues
  11. Tolerance and chimerism
  12. Immune regeneration
  13. Experimental stem cell transplantation
  14. Cancer stem cells
  15. Regenerative medicine
  16. Non-haematopoietic stem cells
  17. Regulatory issues and Quality management

 

Disease-specific topics

  1. Acute leukaemia
  2. Aplastic anaemia
  3. Autoimmune diseases
  4. Chronic leukaemia
  5. Haemoglobinopathy
  6. Inborn errors of metabolism
  7. Lymphoma
  8. Multiple myeloma
  9. Myelodysplasia
  10. Solid tumours

 

 

Nurses Group

 

Care-specific topics

  1. Care of the care-giver
  2. Complementary therapies
  3. Donor issues
  4. Ethical issues
  5. Impact of new therapies on patient care
  6. Outpatient developments
  7. Palliative care
  8. Patient information and education
  9. Protective care
  10. Psycho-social issues
  11. Sexuality
  12. Standards of care
  13. Symptoms management
  14. Education and support of nurses
  15. Management
  16. Survivorship

 

 

Data Management Group

 

  1. Data Management
  2. Statistics

 

 

 

Abstract submission has been closed.